Regeneron Pharmaceuticals Inc (NASDAQ:REGN)

323.86
Delayed Data
As of Feb 23
 +8.04 / +2.55%
Today’s Change
313.53
Today|||52-Week Range
543.55
-13.86%
Year-to-Date

Today’s Trading

Previous close315.82
Today’s open318.06
Day’s range315.15 - 323.90
Volume688,703
Average volume (3 months)932,376
Market cap$34.9B
Data as of 4:00pm ET, 02/23/2018

Growth & Valuation

Earnings growth (last year)+34.29%
Earnings growth (this year)+12.53%
Earnings growth (next 5 years)+16.00%
Revenue growth (last year)+20.82%
P/E ratio31.3
Price/Sales7.42
Price/Book5.67

Competitors

 Today’s
change
Today’s
% change
SHPGShire+1.03+0.82%
VRTXVertex Pharmaceutica...+8.31+5.27%
BAXBaxter International...+0.93+1.38%
ALXNAlexion Pharmaceutic...+4.34+3.79%
Data as of 4:00pm ET, 02/23/2018

Financials

Next reporting dateMay 3, 2018
EPS forecast (this quarter)$4.47
Annual revenue (last year)$5.9B
Annual profit (last year)$1.2B
Net profit margin20.41%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Leonard S. Schleifer
Chief Financial Officer &
Senior VP-Finance
Robert E. Landry
Corporate headquarters
Tarrytown, New York

Forecasts